Severe Acute Respiratory Distress Syndrome during Infliximab Therapy in a Patient with Crohn Disease

Severe Acute Respiratory Distress Syndrome during Infliximab Therapy in a Patient with Crohn Disease

The occurrence of a noninfectious interstitial lung disease is a rare but life-threatening side effect of infliximab, an antitumor necrosis factor alpha antibody. The following case report of a patient with Crohn disease shows an extremely dramatic progression to a severe acute respiratory distress...

Full description

Bibliographic Details
Main Authors: Johanna Schoehl, Nicolae-Catalin Mechie, Harald Schwoerer, Onnen Moerer, Michael Quintel, Cordula Buck, Volker Ellenrieder, Albrecht Neesse, Ahmad Amanzada
Format: Article
Language:English
Published: Karger Publishers 2016-10-01
Series:Case Reports in Gastroenterology
Subjects:
Infliximab
Crohn disease
Acute respiratory distress syndrome
Noninfectious interstitial lung disease
Online Access:http://www.karger.com/Article/FullText/450676

Internet

http://www.karger.com/Article/FullText/450676

Similar Items